Therapeutic Use (Phase IV)

1,197 trials 558 recruiting

Filter these 1,197 trials by condition, country, sponsor and more.

Open in Search →

Multicentre, open-label, randomised, two-arm, parallel-group, superiority trial to assess bioavailability and practicability of two once-dai… Ended

2023-503531-18-00 Prophylaxis of transplant rejection in adult kidney all 2024-02-13
The MERINO trial Ended

2023-510523-30-00 Erosive hand osteoarthritis 2024-02-09
EVOLVE-MI Ended

2023-509268-26-00 Dyslipidemia 2024-01-08
Aspirin to prevent cardiovascular events in patients with pneumonia or influenza Ended

2023-504553-12-01 Influenza 2023-12-27
Early versus postponed supplementary parenteral nutrition after major emergency abdominal surgery Ended

2023-505378-14-00 Major emergency abdominal surgery 2023-10-18
ANTELOPE – Atezolizumab/Carboplatin/nab-Paclitaxel vs. Pembrolizumab/Platinum/Pemetrexed in metastatic TTF-1 negative lung adenocarcinoma Ended

2023-505054-17-00 metastatic TTF-1 negative lung adenocarcinoma 2023-09-15
Safe, effective and cost-effective oxygen saturation targets for children and adolescents with respiratory distress: a randomized controlled… Ended

2023-504817-56-00 Bronchiolitis 2023-09-05
DUPI REDUCE trial (DUPIlumab dose REDUCtion in patients with controlled atopic Eczema): a multicenter, low-intervention, non-inferiority ran… Ended

2023-504171-24-00 Atopic eczema 2023-08-14
Investigation of tissue-resident memory T-cells and disease MEMory in psoriasis during GUSelkumab treatment. The GUSMEM study. Ended

2023-503776-25-00 Psoriasis vulgaris 2023-06-19
A CLINICAL TRIAL TO CONFIRM THE EFFICACY OF OLAPARIB IN COMBINATION WITH BEVACIZUMAB, ADMINISTERED AS MAINTENANCE THERAPY AFTER A FRONTLINE … Ended

2022-502242-27-00 Patients with a confirmation of advanced, high grade ep 2023-06-16
Semmelweis Lipid Center for High-risk Patients Ended

2024-519058-35-00 primary hypercholesterolaemia (heterozygous familial an 2023-05-30
“Randomized, double-blind clinical trial to assess the efficacy of tranexamic acid in reducing blood loss in patients with hip fracture”. Ended

2024-519349-31-00 Hip fracture 2023-05-17
Impact of opioids on heart rate during rapid sequence intubation : Double-blind randomized controlled study (CANDY-CRASH). Ended

2022-501500-10-00 55-65 years old patients with ASA > 3 or patients over 2023-05-16
Noisy Rebels; Non-inferiority study of rituximab compared to ocrelizumab in relapsing MS Ended

2022-502664-21-00 multiple sclerosis 2023-05-01
Biologic treatment of rhinosinusitis with nasal polyposis in real-world Danish patients - a direct comparison of dupilumab and mepolizumab Ended

2022-502250-14-00 Chronic rhinosinusitis with nasal polyposis 2023-04-13
DANNOAC- The Danish Non-vitamin K Antagonist Oral Anticoagulation Study Ended

2022-501912-32-00 Atrial Fibrillation (and atrial flutter), deep vein tro 2023-04-01
A multicenter study of secukinumab, with a randomized double-blind, placebo-controlled withdrawal-retreatment period, to evaluate maintenanc… Ended

2023-509320-17-00 non-radiographic axial spondyloarthritis 2023-03-28
Dupilumab step-down strategy to maintain remission in adult and adolescents patients with atopic dermatitis: a non-inferiority randomized tr… Ended

2022-501179-23-00 atopic dermatitis 2023-03-08
Does progesterone luteal phase support increase live birth rates in couples undergoing intra-uterine insemination with Mild Ovarian HyperSti… Ended

2022-501534-33-00 Unexplained Subfertility, infertility 2023-03-06
REDUCE PMR: Rituximab Effect on Decreasing glUcoCorticoid Exposition in relapsing PolyMyalgia Rheumatica Ended

2024-513545-37-00 Polymyalgia rheumatica 2023-02-09
Bicarbonate for the treatment of cardiac arrest Ended

2022-501304-10-00 In-hospital cardiac arrest 2023-02-06
A Registry Study of Treatment With Bulevirtide in Participants With Chronic Hepatitis D Infection Ended

2022-501901-10-00 Chronic Hepatitis D Infection 2023-02-06
The effect of systemic antibiotics on post-surgical complications and patient-centered outcomes in patients undergoing implant surgery with … Ended

2024-511366-36-00 implant surgery with guided bone regeneration and simul 2022-12-29
Affective effects of pre-surgery opioids (AFFECT2): a randomized, doubleblind placebo-controlled trial Ended

2024-518308-37-00 Health status ASA1 or ASA2 as categorised by a medical 2022-12-13